Pirfenidone treatment of idiopathic pulmonary fibrosis. - Wikidata - thesis-toulmin - TriplyDB

Pirfenidone treatment of idiopathic pulmonary fibrosis.

Pirfenidone treatment of idiopathic pulmonary fibrosis.

http://www.wikidata.org/entity/Q34574174

about

Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosis Role and New Insights of Pirfenidone in Fibrotic Diseases Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis.Inhibition of fibrosis and inflammation by triple therapy with pirfenidone, edaravone and erythropoietin in rabbits with drug-induced lung injury: comparison of CT imaging and pathological findings.A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis.New approaches to modulating idiopathic pulmonary fibrosis.Regulation and Relevance of Myofibroblast Responses in Idiopathic Pulmonary Fibrosis.TRAIL-Dependent Resolution of Pulmonary Fibrosis.

P2860

Q26750418-A67AB88E-B506-4C1B-A0A3-6AB77E6DB879 Q26774154-2DD3DBBF-DB43-4F24-A3D0-21C41502D52E Q36605083-F9D687EF-B319-44B3-989A-A7BDF178EC52 Q37289134-F98D16C0-579F-4401-AE27-056ABEC9930D Q37628170-57E528C3-D49A-404F-AEAF-F294DB5FA8F2 Q38130161-A91A298A-CE1F-435A-991A-1F606F8A798C Q38364228-7D183883-051F-4705-8F50-0CEE65E8D85A Q55543508-4C30E180-0925-47FC-B891-C7D15B91DABD

P2860

Pirfenidone treatment of idiopathic pulmonary fibrosis.

http://www.wikidata.org/entity/Q34574174

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pirfenidone treatment of idiopathic pulmonary fibrosis.

@ast

Pirfenidone treatment of idiopathic pulmonary fibrosis.

@en

Pirfenidone treatment of idiopathic pulmonary fibrosis.

@nl

type

label

Pirfenidone treatment of idiopathic pulmonary fibrosis.

@ast

Pirfenidone treatment of idiopathic pulmonary fibrosis.

@en

Pirfenidone treatment of idiopathic pulmonary fibrosis.

@nl

prefLabel

Pirfenidone treatment of idiopathic pulmonary fibrosis.

@ast

Pirfenidone treatment of idiopathic pulmonary fibrosis.

@en

Pirfenidone treatment of idiopathic pulmonary fibrosis.

@nl

P1433

Q34574174-E4E51E94-8CEE-4583-842C-5B60245750B6

P1476

Q34574174-4EB65691-85D6-4728-91FE-ABBD162B674F

P2093

Q34574174-EB3C9B5E-F1AE-46FE-96A2-0C905738D0B2

Q34574174-FC188B4A-1987-4C4A-8B38-B0428988741F

P2860

Q34574174-01CB82B7-4B32-4EF1-87E0-88ABA7FD8F25

Q34574174-04460FBC-9A06-4081-BB33-5A22BBD49E23

Q34574174-097FFA05-1655-4F72-BEB9-AA03B6E7E56D

Q34574174-0D411854-C9F3-4B06-B908-8B160C6697F1

Q34574174-18C0B751-363F-40E9-8484-38162C79C103

Q34574174-1DD6A61F-34F8-4A71-AEE2-0E96CB55116F

Q34574174-1F71CB60-25A4-4C08-8D55-69F69ACCAFFF

Q34574174-1FF6A113-FF9F-413F-BC82-03B47DEE0C2A

Q34574174-2BB653A3-F610-434C-8660-B3E465382388

Q34574174-2BBD7BEE-525F-40F2-AD8A-A9891AE55B54

P304

Q34574174-40A80263-21C9-44DD-AB57-2C8FE2B49BB0

P31

Q34574174-A230C039-AB82-48D7-96B2-2A4DF465AC5C

P356

Q34574174-DD0474DF-E34C-418C-A8C1-7F0AAB5739C2

P478

Q34574174-40DD9909-A4A7-48FA-A8A4-C9C1FBDCDC13

P50

Q34574174-AE476653-68D0-477F-9475-03D1225DF5FD

P577

Q34574174-C92ED319-95CB-433F-B67D-DDCCC8AC27A5

P698

Q34574174-3D73127C-8531-4DAD-B0A9-A64AD5C43CD8

P921

Q34574174-F35DC9C7-201F-4580-A27B-C32F00AA0C3A

P932

Q34574174-6794256A-55DA-46A4-964E-07CEBD8AF1EB

P356

P1433

Therapeutics and Clinical Risk Management

P1476

Pirfenidone treatment of idiopathic pulmonary fibrosis

@en

P2093

Erica L Herzog

http://www.w3.org/2001/XMLSchema#string

Ye Gan

http://www.w3.org/2001/XMLSchema#string

P2860

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Pirfenidone in idiopathic pulmonary fibrosis

High-dose acetylcysteine in idiopathic pulmonary fibrosis

Advances in the management of idiopathic pulmonary fibrosis.

Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.

The clinical course of patients with idiopathic pulmonary fibrosis.

Incidence and prevalence of idiopathic pulmonary fibrosis.

Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias.

P304

39-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S12209

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Richard H Gomer

P577

2011-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21339942

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

3039013

http://www.w3.org/2001/XMLSchema#string